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Antiretroviral adherence perspectives of pregnant and postpartum women in Guyana: barriers 
and facilitators 
Introduction 
Advances in antiretroviral therapy (ART) for HIV-positive pregnant and postpartum women have 
resulted in delayed disease progression, improved maternal health and significant reductions in 
mother-to-child transmission of HIV (MTCT). To sustain these gains, high levels of ART adherence 
are needed, yet a recent systematic review reported that only 74% of pregnant women achieved 
optimal adherence 1. 
Recently updated ART treatment guidelines from the World Health Organization recommend lifelong 
ART for all pregnant and breastfeeding women irrespective of CD4 level or clinical stage2, meaning 
that women now have to adhere longer than with previous regimens, which may make sustained 
adherence difficult. ART adherence is complex, as a variety of factors can influence outcomes. These 
factors can be grouped into three categories: treatment – ARV regimen and its effects 3,4;  patient - 
socioeconomic and psychosocial factors 4-7; and the health care system - access to health care, support 
from healthcare staff, and drug availability 4,7,8. 
Given the multiplicity of factors that can affect adherence, the need to customize interventions for the 
individual is recognized, as is the need to start interventions prior to ART initiation to offset 
misinformation, fears, stress and depression 9. Among pregnant women there may be little time for 
this preparation or customization prior to initiating ART.  In addition, women may have to grapple 
with issues surrounding their newly diagnosed status and the impending pregnancy. 
The Caribbean region has an estimated adult HIV prevalence of 1.1%10, the second highest after Sub-
Saharan Africa. Guyana’s adult HIV prevalence is 1.4% in the general population11, and 1.9% among 
pregnant women11, with women accounting for an estimated 58.1% of all persons living with HIV10.  
Guyana, the only English speaking country in South America has a population of 767,10012 and an 
estimated 9300 persons living with HIV10 with 85.2% of eligible patients receiving ART11. The 
country has a generalised HIV epidemic with heterosexual sex being the primary mode of 
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transmission11. Patients have universal access to antiretroviral therapy with ART treatment services 
provided free-of-cost at all public health sector facilities. With effect from 2013, the country 
commenced provision of lifelong ART for HIV-positive pregnant women13. 
Despite the relatively high HIV prevalence, there are few studies on adherence to ART in the 
Caribbean,14-20 none from Guyana, and none focusing on adherence in pregnancy and the postpartum 
period. Thus, there is the need to expand on current knowledge in order to provide information for 
developing policies and improving national treatment programmes catering to the dynamics of the 
epidemic. This paper reports the findings of a qualitative study which explored the perspectives of 
HIV-positive pregnant and postpartum women, and healthcare providers about barriers and facilitators 
to ART adherence in Guyana. 
Methods 
Study setting 
The study was conducted within two of the ten Administrative Regions of Guyana, Regions 3 and 4. 
Region 4 which includes the capital Georgetown, is the most heavily populated region with 41.3% of 
the population, and the two regions contribute to 55% of the total population and 80.1% of reported 
HIV cases11. Participants were recruited from five public-sector health facilities: West Demerara 
Regional Hospital; Campbellville Health Centre; Dorothy Bailey Health Centre; Beterverwagting 
Health Centre; and Georgetown Public Hospital Corporation. All study sites provide comprehensive 
HIV treatment and care services free-of-charge, and also provide primary and other specialized health 
care services to the general population. 
Guyana’s HIV cascade of care includes: patient-initiated or provider-initiated rapid HIV testing and 
counselling; referral for treatment at specialized HIV clinics or health centres; free antiretroviral 
drugs, clinical monitoring and diagnostic tests; case management; and treatment support inclusive of 
support groups and home-based care. 
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Sampling 
Participants were selected through homogenous sampling method21, a purposive technique to choose a 
group based on similar characteristics to obtain an in-depth understanding of the determinants and 
characteristics of ART adherence. Clinic patients were selected to include similar numbers of 
pregnant and postpartum women who had delivered in the last year. They had to be at least 16 years 
of age, HIV-positive, had to have initiated ART prior to or in the current pregnancy, and able to give 
consent. The primary author was facilitated by the nurse supervisor to identify patients typical of the 
target group. Healthcare staff comprised social workers, nurses and doctors and were eligible if they 
provided care to HIV-positive women at the facility. Participants were selected until no new 
information was obtained from the interviews (saturation).  
Data collection 
Data were collected between February and April 2012 using semi-structured interviews. The primary 
author interviewed 24 pregnant and postpartum women and nine healthcare providers. Interviews 
were conducted in English at the clinics and averaged 30 minutes. Interviews were audio recorded 
with participants’ consent. 
The interview topic guides were developed taking into consideration the literature on adherence and 
PMTCT 22-36 and were pretested by independent researchers with experience in the field, local 
healthcare providers and resident. The guides for the HIV-positive women captured participants’ 
experiences relating to adherence and HIV treatment and care, including: living situation; experiences 
with their HIV diagnosis; disclosure; issues around mental health and coping; pregnancy thoughts, 
desires and expectations.  Healthcare providers’ guide included questions on: role in the clinic; 
treatment criteria and response; women’s adherence; strategies by health workers to improve 
adherence; and infant feeding.  
The study was granted ethical approval from the Guyana Ministry of Health Institutional Review 
Board (Protocol #48), and University College London (ID 3518/001). Written informed consent was 
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obtained from all research participants and code numbers used for participants throughout the 
manuscript. 
Analysis 
Interviews were transcribed verbatim, maintaining the creole used, and all transcripts were double-
checked against the voice data files for completeness and accuracy. The authors used the Framework 
Method (FM) for managing and analysing qualitative data 37,38, which includes five steps as follows: 
Familiarization – in-depth knowledge of the data by listening to the audio recordings, reading the 
transcripts and associated notes; Thematic analysis – developing codes; Indexing – applying the codes 
to relevant segments of the data transcripts; Charting – use of a spreadsheet to reduce the volume of 
data by creating summaries or snapshots of the data in cells aligned with key themes, tagged to the 
relevant participant. This process allows the researcher to see and compare relationships within and 
between  codes; and Mapping and interpretation – to identify and generate concepts or themes 
emanating from the data and explore any associations within those relationships. 
The first step in the analysis process entailed multiple readings of the transcripts. Initial coding was 
generated from themes in the interview guides and the research questions. The authors (DV, ZH) 
initially hand coded the same transcripts to increase coding rigour and identify new codes. A coding 
framework was then developed in NVivo 10 qualitative data analysis software 39 and codes assigned 
to the transcripts. During this process, additional codes were created to identify other themes that 
emerged in the transcripts and did not fit established codes, and themes were merged and reorganized 
as needed. In addition, a framework matrix was designed for the major themes containing brief 
sections of the relevant quote in the corresponding cell. The coding process was reviewed and 
discussed with the other co-author. 
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Results 
Sample characteristics 
Clinic patients were all Guyanese nationals, 11 pregnant and 13 postpartum, aged 18 to 39, median 
age 28 (Table 1). Three of the women were prima-gravidas, while the others already had children. 
More than half of the clinic patients (14) had been diagnosed with HIV during the current or previous 
pregnancy, and only two pregnant women had been prescribed ART for the first time in the current 
pregnancy. The nine healthcare providers included all eligible clinic staff (three doctors, one medex, 
four midwives and one social worker). They ranged in age from 28 to 61 years, with the majority 
having a university education and being of Christian faith. All were Guyanese nationals, except one 
Cuban doctor. Health workers’ experience providing care and support to HIV-positive women ranged 
from one year to twelve years, with an average of seven years of experience (Table 2). 
 Impact of pregnancy on adherence 
The majority of the pregnant, as well as postpartum women reported that they were always adherent 
during pregnancy, with reported differences between adherence in the pregnancy and postpartum 
period. Those who were not adherent usually missed doses ranging from one or two days to a week at 
a time, and some reported that they did not disclose their non-adherence to their health workers. 
Women who had been non-adherent before getting pregnant stated that they took their ART better 
during pregnancy (to reduce the risk of HIV transmission to the baby), which was confirmed by the 
health workers. Overall, adherence emerged as being better during pregnancy, as this period appeared 
to have a positive influence on the women’s ability to adhere. 
I: …when you’re pregnant you’re taking them better?  
P: Yea  
I: And why were you taking them better when you’re pregnant? 
P: To avoid the mother to child transmission disease  
I: Ok, any other reason?  
P: Fa [for] betta health for the baby, fa nothing doan wrong with me along with da chile [child], an 
fa jus protection (29-year old, housewife, postpartum, 3 children) 
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“I would say pregnancy, because they within their cognitive they’re thinking this is a short term thing 
and they adhere well during that period;  … that whatsoever should happen after, let it happen but 
once the baby is safe” (Provider: 28-year old male Social Worker) 
In the section below, we discuss the main themes derived from the analysis: (1) concern for the 
wellbeing of children; (2) ART-related factors; (3) disclosure; (4) social and economic issues; and (5) 
religious and cultural beliefs (Table 3). 
Theme - Concern for the wellbeing of their children 
Desire for a healthy child enhances adherence 
An overwhelming desire for a healthy baby was a strong motivator for most of the pregnant women to 
diligently adhere to their ART regimens, or for those who had skipped or missed, to get back on track. 
Women who had not been compliant before pregnancy reported taking ART better during pregnancy:  
“…because I didn’t want my child to be HIV-positive.” (31-year old housewife, postpartum, 1 child) 
Healthcare providers also reported that the desire for a healthy baby contributed to better adherence:  
I: …What are some of the factors that help the women take their medication, the pregnant women, 
what do you think helps them to take their medication? 
P: The fact that they don’t want their children to get infected. (Provider: 53-year old Midwife) 
 
Women who had planned their pregnancies or indicated really wanting the baby reported a 
particularly strong desire to adhere to their medication. 
Desire to care for their children enhances adherence 
Some mothers were worried about the wellbeing of their children if they should get very ill or die, and 
having other children was a key theme related to adherence, which was also reported by health 
workers. Women reported the desire to care for their children as giving them the courage to live, even 
though some reported contemplating suicide. 
“Right now I ask de father, I want to live to see me two children dem, this unborn one, and me other 
daughter outside…” (22-year old, pregnant, housewife, 1 child) 
P: I had want to commit suicide, kill meself, but 
I: And what prevented you from doing that? 
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P: I remember I have three children to live for (22-year old housewife, postpartum, 3 children) 
Theme – ART-related factors 
ART side effects inhibits adherence 
Medication side effects were one of the primary reasons given for non-adherence, and women 
indicated that intolerable side effects were the reasons for their intermittent or complete non-
adherence. Women experienced side effects irrespective of whether they were prescribed the fixed-
dose or multiple compound regimen, which ranged from mild or moderate (feeling faint, drowsiness, 
headache, upset stomach) to quite severe (vomiting, diarrhoea, feeling intoxicated, nightmares). 
P: I does feel drowsy, drowsy; Sometime, when I feel bad, I does vomit. Every time I drink it, I does 
vomit, so I don’t drink it…  
I: Ok and um how many drugs you have to take right now? 
P: Seven 
I: And have you been taking it now? 
P: They get me vomiting so I does drink it every other day (22-year old, pregnant, security guard). 
 
Although the side effects of the medication were a hindrance to good adherence for some women, 
others found solutions to cope with their discomforts. For example, women on the fixed-dose 
combination drug took their medication prior to retiring for bed in the evening, thereby eliminating 
those “bad” feelings and woke up refreshed the following day. 
I: Ok, and how do you feel after you take this um one tablet once a day? 
P:  I feel like I’ve drink two bottles of vodka. 
I: Two bottles of vodka, wow! 
P:  Large bottles of vodka. I feel really intoxicated, like I was just at a rum shop and all I was doing is 
sitting there and drinking 
I: Oh, ok, what do you do when you get that feeling? 
P: I go in my bed and lie down and sleep, sleep it off. 
I: And then, how you do feel afterwards when you wake up? 
P: You wake fresh, you don’t feel anyway (18-year old, hairdresser, pregnant). 
Regime simplicity 
The fixed-dose combination of once-daily Atripla was a more convenient regimen for the women, 
even among those who experienced side effects and enabled better adherence, particularly among 
those who had been on a multiple compound regimen. 
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I: So this pregnancy they put you on one tablet now, so you only take that at night? 
P: Yes 
I: Ok and since you’ve been put on this one tablet, have you stopped at any time? 
P: No, I don’t 
I: Have you ever skipped a dose? 
P: No 
I: You never forget to take it at night? 
P: No (29-year old, pregnant, Domestic, 4 children) 
Theme - Disclosure 
Disclosure does not influence adherence 
Almost all women had disclosed to at least one person, but were wary of relatives reacting badly, with 
some women only disclosing to a friend out of fear of being shunned by relatives or partners. For 
some women, living arrangements and reactions to disclosure were sources of stress, with some 
experiencing stigma and discrimination, such as verbal abuse, being shunned, or having to use 
separate utensils, and uncomfortable or unhealthy living conditions. Despite the varied experiences 
with disclosure, no strong theme emerged related to disclosure and adherence, with women who had 
not disclosed finding creative ways to store and take their ART. However, health workers reported 
that non-disclosure contributed to non-adherence. ART medication was stored in handbags, closets, 
and in a suitcase under the bed. One 32-year old housewife described taking her ART whenever her 
family visited for a few days as having “to hide and sneak to use the medication.”  
P: It’s a big experience right now to me because it’s like I’m taking the tablets and if my family 
around I have to hide, I have to have it lock up in the drawer and those things. And when they’re not 
around, I could take out my tablets before 8 and I would have it with me and I’ll go drink them…Now, 
if they’re around…I have to hide and sneak to use the medication 
I: What, how do you take it when they’re around? 
P: Sometimes I would take the medication out and they would be outside talking to me and I’ll say 
excuse me one minute and I’ll go inside and take up the medication and have it on me in my pocket, or 
have it on me somewhere and then me say I have to go to de washroom and I take it. Sometimes I take 
it into the washroom. I don’t miss it, I don’t miss my medication, I don’t (32-year old, pregnant, 
housewife, 2 children). 
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Theme - Social and economic issues 
Inadequate food and finances inhibits adherence 
Both clinic patients and healthcare staff indicated that inadequate food and lack of finances were 
deterrents to adherence. About half of the pregnant women who were non-adherent cited lack of food 
as the reason for skipping doses. These women divulged that taking ART on an empty stomach would 
give them “bad feelings” or make them feel sick. Many of the women interviewed were dependent on 
family or a combination of family and partner for financial support. Some women were unable to 
attend their clinic appointments due to lack of money for transportation, while others sometimes 
borrowed money to do so. 
P: Well right now my worry is finance, finance, money, that does give me headache right now, cause 
I’m not working. Right now my brother is at home, he ain’t working, my mother doan work, so fo [to] 
come to clinic today is borrow I had to borrow a $1000 (US$5)  from a friend, till when my brother 
get money he give me and I could pay her back. (34-year old, housewife, postpartum, 2 children) 
I: Ok and how many appointments have you missed? 
P: Not much 
I: And what’s the reason for you being unable to come to the appointments? 
P: Like financial problems 
I: Financial. Any other problems?  
P: No (29-year old, housewife, postpartum, 2 children) 
Some of the women reported that they were unable to take their medication due to lack of food, with 
health workers also reporting that women were unable to take their medication on an empty stomach. 
I: How often did you use to miss? 
P: Say that ah drink today, I might skip tomorrow, drink de nex day 
I: And how often you would do that for? 
P: Not all steady, but sometimes like if I don’t have like food or things to eat, that day I gon skip (34-
year old, housewife, postpartum, 2 children). 
The National AIDS Program Secretariat (NAPS) has an active food bank, but some women did not 
seem to benefit from this resource, with one clinic occasionally providing their clients with rations 
obtained through their own resources. 
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Theme - Religious and cultural beliefs 
Religious and cultural beliefs had a mixed impact on adherence 
Some postpartum women’s beliefs that religion would cure them resulted in non-adherence to their 
medication. These women hoped to be healed by God and attended churches where pastors boasted of 
their ability to heal those afflicted with the disease as described by this midwife:  
“…they would drop [out of clinic] for three, four months and they gon [will] call and say they been to 
some Pentecostal church and de [the] Pastor say they heal, and they ain’t got need for treatment…” 
(Provider: 61-year old midwife).  
A few women believed that there were some indigenous cures, for example, a pregnant woman hoped 
to travel to the hinterland to be cured by an indigenous person (Amerindian), but only once the baby 
was born in case the ‘cure’ was harmful. 
I: You never tried any [bush medicine]? 
P: Them seh because ah pregnant.  
I: Because you’re pregnant? 
P: Yeah. 
I: Oh, ok. 
P: When ah done get de baby. 
I: Then you’ll take the bush medicine? 
P: Yeah. 
I: You think the bush medicine will work? 
P: It will work, yeah; I have a friend, right.  
I: Uh huh. 
P: And the Amerindian man seh she pick some kinda bush. 
I: Mm hmm. 
P: Fuh get fuh boil it and drink it. 
I: Mm hmm. 
P: And the bush cure she. 
I: She’s now cured? 
P: Yes. And she ain’t got it [HIV]. She went and she tek [took] nuf, nuf [many] test (37-year old, 
pregnant, housewife, 4 children). 
 
Strategies used for remembering medication 
Most women had ways of remembering to take their medication. Some women incorporated taking 
ART into their daily routine, so that it became a “normal” part of their lives. Other women relied on 
their watches, clocks or cell phone alarms, or associated taking their medication with routine activities 
like watching a particular television program, while others were reminded by relatives or children.  
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Clinic support and women’s views of health system 
Health workers utilized a variety of measures to enhance patients’ adherence. Nurses, social workers 
and pharmacists were tasked with counselling patients throughout enrolment. Some clinics had active 
support groups. Others provided pill boxes and frequent reminders during clinic visits. A majority of 
the pregnant and postpartum women were satisfied with the services and support they received from 
the staff at the clinics. 
I: And how about this clinic, how have you been treated at this clinic? 
P: Good, actually I enjoy coming here because I love my doctor; an my nurse, an the receptionist 
they’re good - (29-year old, housewife, postpartum, 3 children). 
 
Although some women reported negative experiences at home, in their communities or other health 
facilities, healthcare staff at the study sites should be applauded that none of the women reported any 
occurrences of stigma and discrimination, and appreciated the manner in which they were treated. 
 “…well everybody treat you normal. Nobody don’t discriminate like you have HIV or so, they treat 
you like a normal person” – (21-year old housewife, postpartum).  
Women also valued the staff for maintaining the privacy of their medical information. 
“…Since I’m coming here in 2006, nobody don’t know that I’m HIV-positive. If even if they come here 
and they see me here and they know me, they wouldn’t know that I’m HIV-positive”- (32-year old, 
pregnant, housewife, 2 children). 
Discussion 
The findings from this study highlight some of the myriad issues confronting the women as they 
initiate or maintain their antiretroviral regimens. Similar adherence issues were observed irrespective 
of whether the women were pregnant or postpartum, or lived in urban or rural areas. Barriers 
identified for both pregnant and postpartum women included lack of food, lack of financial resources, 
religious and cultural beliefs, and medication side effects.  Non-disclosure of HIV status was 
identified as a barrier only by healthcare providers. Facilitators comprised concern for the wellbeing 
of the unborn baby or wanting to be around for other children, and were primary motivating factors 
for adherence, that have also been identified in other studies 40-42. To the authors’ knowledge, this is 
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the first study of its kind to explore ART experiences, and the barriers and facilitators of ART 
adherence in pregnant and postpartum women in the Caribbean. 
The findings of this study confirm prior reports that adherence is better during pregnancy than the 
postpartum period 1,43,44, probably because the concern of transmitting the virus to the child is 
heightened during this time. Although some women reported good adherence, there were periods of 
non-adherence in the study population that are cause for concern. 
Food insufficiency has also been reported in the literature as a barrier to ART adherence for HIV 
infected persons including pregnant women 45-48. As well as influencing adherence, food insecurity 
has the potential for adverse outcomes on maternal, foetal and new-born health 47. Despite the 
importance of sufficient food, few women appeared to benefit from the existing food bank. Healthcare 
staff should screen all women for food insecurity and liaise with the food bank to ensure they receive 
the necessary food assistance.  This short-term fix should be coupled with interventions at a higher 
level through poverty alleviation/reduction strategies. 
The unique finding that non-disclosure did not adversely affect adherence contradicts other studies in 
the literature 46,49 as women who had not disclosed their HIV status found innovative ways to ensure 
that ART medication was taken. This reveals the commitment and drive of pregnant women in 
Guyana and should be taken into account when the issue of disclosure and adherence is discussed. 
Non-disclosure is inextricably linked with fear of stigma and discrimination which has been attributed 
to non-adherence in other studies 50-52. The fact that some women reported stigmatising experiences 
from family, community and other health facilities need to be further assessed and remedied, as well 
as the effects of self-stigma/internalised stigma on adherence. It should be noted that consecutive 
Guyana HIV country progress reports describe the continuing “challenge” of stigma and 
discrimination despite the wide-ranging efforts of the Government of Guyana11,53,54. 
Many women found creative solutions to aid their adherence, such as storage of medication to avoid 
inadvertent disclosure, medication reminders and switching dose time to reduce side effects. 
Healthcare workers could capitalize on their clients’ successful strategies and share these with other 
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women with similar concerns during one-to-one counselling, support group, or peer-educator 
sessions.  
The suboptimal level of adherence reported by the pregnant and postpartum women during the in-
depth interviews is a worrying trend that warrants timely intervention for successful treatment 
outcomes. Women should be closely monitored during clinic visits to address potential barriers to 
optimum ART therapy. Research to date on ART medication suggest that non-adherence is primarily 
due to factors beyond the patient’s control such as the health system, regimen and poverty 55,56, of 
which the latter two were identified in this study. Side effects of ART and pregnancy associated 
nausea compounding their experiences would exacerbate negative effects thereby making adherence 
difficult 1.  
It was quite evident from the in-depth interviews that religion had a positive effect for some (when 
used as a coping mechanism), and negative effect for others (non-use of ART because they believe 
they have been healed by a religious leader) on adherence behaviour. Guyana is a deeply religious 
society with diverse religious groups and thus the role that religion/spirituality plays in the lives of 
women vis-a-vis their ART medication should be discussed during treatment and care sessions. An 
assessment by providers when women initiate treatment and at various times throughout the care and 
treatment cycle could ameliorate potential problems as suggested by Trevino, Pargament, Cotton, 
Leonard, Hahn, Caprini Faigin, Tsevat 57 and Wasti, Simkhada, Randall, Freeman, van Teijlingen 49.  
The women in this study expressed depressive symptoms of which the magnitude over time might be 
far greater than actual reports. Future observational studies are warranted to determine the magnitude 
of these mental health issues. In addition, alleviating the economic hardships identified in this study 
(food and finances) has been advocated as another type of intervention to address mental health 
problems since they are both contributors of mental distress 58,59.  
Limitations 
The findings in this study may not reflect the entire population of women with HIV in Guyana since 
participants were recruited from current clinic attendees and did not include the views of women who 
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had dropped out of care. This subset of women would more likely have a higher probability of non-
adherence and may have been confronted with different barriers than those described here. Future 
studies with this key group need to be undertaken. Social desirability may have influenced some 
women to report on what they thought acceptable behaviour than what they actually experienced. To 
reduce this, questions were structured in a way to put the women at ease prior to engaging them in 
discussion of sensitive issues and this may have diminished this effect. Women were also assured that 
individual reports would not be shared with their clinicians. The recall of past events may have 
introduced recall bias, as studies have shown that memory fades with time 60,61. Participants may have 
erred in their recollection of their behaviour over the course of a few days to longer periods of time. 
Conclusion 
The lived ART experiences of women in Guyana can be grouped into two broad categories. The first 
is related to the act of actually taking their medication where their tenacity is displayed in efforts 
made to ensure ART is taken despite non-disclosure of status, utilizing a variety of prompts as 
medication reminders and managing side effects. The second relates to the significance of ART to 
them in terms of reduced risk of MTCT, a healthy baby, and the possibility of better health for 
themselves to enable them to care for their children. However, issues related to poverty, mental 
health, food insecurity and medication side effects reduce adherence and need to be adequately 
addressed.
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